A Chinese national was found dead floating in the river in Pak Tha district, Bokeo province.
Enriching Lives through Excellent Service Hang Lung Frontline Staff “Go the Extra Mile” to Show Their Commitment to Customer-Centricity Amid the Pandemic

Mr. Adriel Chan, Vice Chair (1st from the right), Mr. Weber Lo, Chief Executive Officer (2nd from the left) and senior management of Hang Lung Properties attend the 2022 Hang Lung Emerald Award presentation ceremony to commend frontline staff winners for upholding the service philosophy of customer-centric even amid the pandemic
Mr. Adriel Chan, Vice Chair of Hang Lung Properties, congratulated the winners and said, “Our frontline staff are an indispensable bridge between the Company, our customers and the communities we serve. At the heart of it, they communicate our vision, mission and values through actions that demonstrate their focus on customer-centricity. This year’s Emerald Award winners epitomize what it means to do it well in their vital roles, creating a Hang Lung branded experience to customers, and enriching lives through excellent service.”
Two Emerald Award-winning cases were honored at the ceremony, involving guest services and operational hygiene personnel from Kornhill Apartments in Hong Kong, and Riverside 66 in Tianjin. The first Emerald Award was present for actions with the rescue of a chronically-ill elderly resident living alone, while the second saw the staff member provide proactive assistance to two tourists who are enthusiastic photographers to take their desired photos. The two Emerald Award winning cases and those of the three Merit Award winners demonstrated service excellence in various circumstances, epitomizing the Hang Lung spirit of customer-centricity and “Go the Extra Mile”, which is at the very heart of the Hang Lung Emerald Award.
Mr. Weber Lo, Chief Executive Officer of Hang Lung Properties, said, “We are exceptionally proud of our people for delivering on our brand promise grounded in customer-centricity, and providing assistance from the perspectives of customers even amid the challenges presented by the COVID-19 pandemic in Hong Kong and mainland China.”
Hang Lung takes the “Go the Extra Mile” spirit beyond the provision of exceptional customer service to the community at large, through community investment initiatives like the “Love·No·Limit” program in collaboration with the Hong Kong Young Women’s Christian Association that seeks to build awareness of the needs of people living with dementia, and to equip staff with the skills necessary to provide quality service to people in need.
About Hang Lung Properties
Hang Lung Properties Limited (SEHK Stock Code: 00101) creates compelling spaces that enrich lives. Headquartered in Hong Kong, Hang Lung Properties develops and manages a diversified portfolio of world-class properties in Hong Kong and the nine Mainland cities of Shanghai, Shenyang, Jinan, Wuxi, Tianjin, Dalian, Kunming, Wuhan and Hangzhou. With its luxury positioning under the “66” brand, the company’s Mainland portfolio has established its leading position as the “Pulse of the City”. Hang Lung Properties is recognized for leading the way in enhanced sustainability initiatives in real estate as it pursues sustainable growth by connecting customers and communities.
At Hang Lung Properties – We Do It Well.
For more information, please visit www.hanglung.com.
#HangLungProperties
Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering “Nuclear Power” to The Company’s Performance
“Super nuclear bomb” fills the gap in treatment and helps to overcome liver cancer
SIR-Spheres® Y-90 microsphere injection is a targeted internal radionuclide product for liver malignant tumors, applying the world’s leading interventional technology to inject Y-90 microsphere injection into the blood vessels of the liver tumors and release high-energy beta radiation to kill tumor cells. It is still the only product in the world for selective internal radiation therapy (SIRT) for colorectal cancer liver metastases.
During the 20 years since it was launched, Y-90 microsphere injection has treated more than 120,000 patients worldwide. Its clinical safety and efficacy have been widely recognized, and is recommended by the guidelines issued by different institutions. Since the beginning of this year, many grade-A primary hospitals in Tianjin, Shaanxi, Jiangsu, Hangzhou, Hunan, Liaoning, Haikou and other provinces and cities have successfully performed precision interventional surgery of Y-90 microsphere injection for many patients. At present, all patients that had interventional surgery have undergone SPECT examinations, which are in line with pre-treatment expectations.
As Y-90 gradually enters grade-A primary hospitals in Mainland China, the product will provide a new and effective treatment method for a large number of patients with liver malignant tumors in Mainland China, creating potential surgical resection opportunities, filling the gap in the local treatment of colorectal cancer liver metastases, and marking the landing of a new international precision interventional treatment plan in the field of liver malignant tumors in Mainland China.
Dong Jiahong, academician of the Chinese Academy of Engineering and president of Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University, said: “Y-90 microsphere injection is like a ‘super nuclear bomb’ that can be accurately delivered to kill tumors. Precise manipulation of Y-90 microsphere injection can effectively control patients with advanced liver cancer. Some cases are expected to achieve the effect of downstaging treatment, thus creating opportunities for curative surgery such as liver resection or liver transplantation. It becomes a new blockbuster weapon to overcome liver cancer in Mainland China.”
Fan Jia, academician of the Chinese Academy of Sciences and president of Zhongshan Hospital affiliated to Fudan University, also pointed out that China is a big country with a large number of patients with liver cancer. The medical community has been constantly seeking new methods for the treatment of liver cancer. As a new treatment method for liver cancer, the introduction of Y-90 microsphere injection into the treatment method of Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition), will bring positive and important clinical significance to Chinese doctors and patients.
Grand Pharma strategically plans a whole industrial chain of radionuclide drugs based on Y-90
In addition to being a milestone in the history of liver cancer treatment in Mainland China, the Y-90 microsphere injection also has great value to Grand Pharma.
In recent years, Grand Pharma has been focusing on building its radiopharmaceutical diagnosis and treatment platform with the core of Y-90 microsphere injection. Currently, the Company has established a comprehensive layout in the field of research, production and commercialization worldwide, and three radiopharmaceutical R&D bases and five radiopharmaceutical production bases are set globally. The radiopharmaceutical diagnosis and treatment platform is currently one of the most globalized segments of the Company.
Grand Pharma’s radiopharmaceutical diagnosis and treatment platform now has reserved 10 innovative products, covering 6 nuclides including 68Ga, 177Lu, 131I, 90Y, 89Zr and 99mTc. In terms of indications, it covers 13 cancer types including liver cancer, prostate cancer, colorectal cancer, clear cell renal cell carcinoma, glioblastoma, gastroenteropancreatic neuroendocrine tumors and bone metastases of malignant tumors. Its product types cover two types of radionuclide drugs for diagnosis and treatment, providing patients with multi-indication treatment options, multi-method and integrated diagnosis and treatment of the world’s leading anti-tumor solutions.
From the perspective of market space, there are nearly 400,000 new cases of liver cancer and about 380,000 new cases of colorectal cancer in Mainland China every year, of which about 30-50% of colorectal cancer patients will develop liver metastasis. Most patients are already in the middle and late stages when they are discovered, and the existing treatment options are relatively limited. Y-90 microsphere injection will provide more treatment options for patients with liver cancer in Mainland China.
The official commercialization of Y-90 microsphere injection is an important step in the establishment of the radionuclide diagnosis and treatment platform of Grand Pharma. It is also expected to further improve the production and sales network of radionuclide drugs, and achieve comprehensive localized production in Mainland China. In the future, with the sales volume of innovative products of Y-90 microsphere injection increasing gradually, Grand Pharma’s performance is also expected to empower “nuclear power” and further increase the market value of its product pipeline.
Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering “Nuclear Power” to The Company’s Performance
“Super nuclear bomb” fills the gap in treatment and helps to overcome liver cancer
SIR-Spheres® Y-90 microsphere injection is a targeted internal radionuclide product for liver malignant tumors, applying the world’s leading interventional technology to inject Y-90 microsphere injection into the blood vessels of the liver tumors and release high-energy beta radiation to kill tumor cells. It is still the only product in the world for selective internal radiation therapy (SIRT) for colorectal cancer liver metastases.
During the 20 years since it was launched, Y-90 microsphere injection has treated more than 120,000 patients worldwide. Its clinical safety and efficacy have been widely recognized, and is recommended by the guidelines issued by different institutions. Since the beginning of this year, many grade-A primary hospitals in Tianjin, Shaanxi, Jiangsu, Hangzhou, Hunan, Liaoning, Haikou and other provinces and cities have successfully performed precision interventional surgery of Y-90 microsphere injection for many patients. At present, all patients that had interventional surgery have undergone SPECT examinations, which are in line with pre-treatment expectations.
As Y-90 gradually enters grade-A primary hospitals in Mainland China, the product will provide a new and effective treatment method for a large number of patients with liver malignant tumors in Mainland China, creating potential surgical resection opportunities, filling the gap in the local treatment of colorectal cancer liver metastases, and marking the landing of a new international precision interventional treatment plan in the field of liver malignant tumors in Mainland China.
Dong Jiahong, academician of the Chinese Academy of Engineering and president of Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University, said: “Y-90 microsphere injection is like a ‘super nuclear bomb’ that can be accurately delivered to kill tumors. Precise manipulation of Y-90 microsphere injection can effectively control patients with advanced liver cancer. Some cases are expected to achieve the effect of downstaging treatment, thus creating opportunities for curative surgery such as liver resection or liver transplantation. It becomes a new blockbuster weapon to overcome liver cancer in Mainland China.”
Fan Jia, academician of the Chinese Academy of Sciences and president of Zhongshan Hospital affiliated to Fudan University, also pointed out that China is a big country with a large number of patients with liver cancer. The medical community has been constantly seeking new methods for the treatment of liver cancer. As a new treatment method for liver cancer, the introduction of Y-90 microsphere injection into the treatment method of Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition), will bring positive and important clinical significance to Chinese doctors and patients.
Grand Pharma strategically plans a whole industrial chain of radionuclide drugs based on Y-90
In addition to being a milestone in the history of liver cancer treatment in Mainland China, the Y-90 microsphere injection also has great value to Grand Pharma.
In recent years, Grand Pharma has been focusing on building its radiopharmaceutical diagnosis and treatment platform with the core of Y-90 microsphere injection. Currently, the Company has established a comprehensive layout in the field of research, production and commercialization worldwide, and three radiopharmaceutical R&D bases and five radiopharmaceutical production bases are set globally. The radiopharmaceutical diagnosis and treatment platform is currently one of the most globalized segments of the Company.
Grand Pharma’s radiopharmaceutical diagnosis and treatment platform now has reserved 10 innovative products, covering 6 nuclides including 68Ga, 177Lu, 131I, 90Y, 89Zr and 99mTc. In terms of indications, it covers 13 cancer types including liver cancer, prostate cancer, colorectal cancer, clear cell renal cell carcinoma, glioblastoma, gastroenteropancreatic neuroendocrine tumors and bone metastases of malignant tumors. Its product types cover two types of radionuclide drugs for diagnosis and treatment, providing patients with multi-indication treatment options, multi-method and integrated diagnosis and treatment of the world’s leading anti-tumor solutions.
From the perspective of market space, there are nearly 400,000 new cases of liver cancer and about 380,000 new cases of colorectal cancer in Mainland China every year, of which about 30-50% of colorectal cancer patients will develop liver metastasis. Most patients are already in the middle and late stages when they are discovered, and the existing treatment options are relatively limited. Y-90 microsphere injection will provide more treatment options for patients with liver cancer in Mainland China.
The official commercialization of Y-90 microsphere injection is an important step in the establishment of the radionuclide diagnosis and treatment platform of Grand Pharma. It is also expected to further improve the production and sales network of radionuclide drugs, and achieve comprehensive localized production in Mainland China. In the future, with the sales volume of innovative products of Y-90 microsphere injection increasing gradually, Grand Pharma’s performance is also expected to empower “nuclear power” and further increase the market value of its product pipeline.
Shopee to help local sellers boost sales with more collaborative features
Shopee shared initiatives and resources to support local businesses at Seller Summit 2022
KUALA LUMPUR, MALAYSIA – Media OutReach – 20 June 2022 – Shopee seeks to help local sellers attract more new and returning customers on the platform with new and more collaborative seller marketing tools.

According to Kavan Sito, Director of Shopee Malaysia, starting Q3 this year, all sellers can expect to expand their reach through over 13,000 Shopee affiliate partners to gain a wider audience and boost sales via Shopee Affiliate Marketing Solution (AMS).
The affiliate partners include social media influencers, coupon and cashback platforms, price comparison platforms and content publishers.
Selected sellers who participated in AMS between October and December last year achieved up to 16 times return on their advertisement investment.
Speaking at the Shopee Seller Summit on 16 June, Sito said that reviews are essential to help create trust and appeal for a product online. As such, Shopee will also be enabling sellers to reward users for leaving useful product reviews.
Apart from that, the platform will also be enhancing its voucher features that will enable sellers to incentivise new buyers as well as reward repeat buyers for their loyalty.
“These are among many innovative seller marketing features that Shopee will be launching in the coming months to help sellers drive long-term business growth,” Sito said.
The Shopee Seller Summit-themed “Level Up: Driving Growth Together” was held at Sunway Resort, Petaling Jaya, attracting 500 physical and close to 2000 virtual participants.
Sito said, “Shopee remains committed to upskilling and empowering local businesses. Apart from free training modules provided through Shopee University, Shopee is glad to be the trusted partner of government agencies to support local communities and drive training initiatives that help to upskill local businesses. This includes supporting sellers of all types, even some 5,000 university student entrepreneurs kickstarted their online selling journey through the Siswa Mall initiatives in collaboration with the Ministry of Higher Education.”
Shopee Seller Summit is also part of the #ShopeeSapotLokal initiative that aims to drive inclusiveness and create more opportunities for local communities.
An avid user of Shopee’s programmes such as Facebook Collaborative Ads (CPAS) and Seller Affiliate Programme, 46 years old Kelvin Yam, who runs a stationery store – CX Trading on the platform said that the programmes had not only incentivised him to market his Shopee products on Facebook but also helped increased his average monthly sales by more than double.
“These programmes were very helpful for me to scale my Shopee business as I saw an almost 5X increase in sales. I am now generating an average monthly sales of about RM50,000,” Yam said.
Another seller, Ammar Izzuddin, 33 believes that beyond learning, one also needs to network and learn from other sellers to gain further experience in selling.
Ammar who sells baby products on Shopee said, “Through the networking opportunities at the Shopee Seller Summit, I gained insights on how other sellers strategise and forecast business opportunities, as well as manage their resources. These are all very insightful to help us understand how we can do better and scale in the long run.”
Ammar has been a loyal participant of Shopee Seller Summit for four consecutive years.
Sellers looking to impart their skills and knowledge can look forward to the ShopeeXperts programme applications in early August this year. Through this programme, selected top-performing sellers will be given an insightful 1-month training in marketing, operations, sales and presentation skills. This is a chance to establish credibility as qualified trainers and be able to help other sellers to drive growth for their businesses.
About Shopee
Shopee is the leading e-commerce platform in Southeast Asia & Taiwan. Shopee promotes an inclusive and sustainable digital ecosystem by enabling businesses to digitalise and grow their online presence, helping more people access and benefit from digital services, and uplifting local communities.
Shopee offers an easy, secure, and engaging experience that is enjoyed by millions of people daily. Shopee is also a key contributor to the region’s digital economy with a firm commitment to helping homegrown brands and entrepreneurs succeed in e-commerce.
Shopee is part of Sea Limited (NYSE: SE), a leading global consumer internet company. Sea’s mission is to better the lives of consumers and small businesses with technology through its three core businesses: Shopee, Garena and SeaMoney.
#Shopee
The issuer is solely responsible for the content of this announcement.
“Recycle Your Bottles” at Starstreet Precinct
Recycle Plastic Bottle and Plant a Tree – Through an Interactive 4-Step Recycling Programme
Let’s contribute to building the upcycled festive Christmas decorations
HONG KONG SAR – Media OutReach – 20 June 2022 – Have you ever thought of giving a new life to your used plastic bottles? With its continued efforts to promote eco-friendly initiatives, Starstreet Precinct is offering a “Recycle Your Bottles” initiative to collect recyclable plastic bottles and use them for building the Christmas decorations, while as a token of appreciation, a new tree will be planted on behalf of you.

Starting from 20 June 2022, Starstreet Precinct will be setting up 16 limited-time PET plastic bottle recycle points within the Admiralty and Wan Chai neighbourhood. With only four simple recycling steps, successful participants will be rewarded with a tree planted on their behalf, by EcoMatcher’s Global Forest Program, in a forest in Nepal. Participants can name the tree, and keep track of the tree’s exciting growth progress, in addition to its species and carbon sequestration, on the EcoMatcher platform. This hopes to enhance the awareness of the public towards cherishing our environment.
Starstreet Precinct partners with Hong Kong-based New Life Plastics, a Joint Venture between Baguio, ALBA and Swire Coca-Cola, to process the collected post-consumer PET bottles at its state-of-the-art EcoPark facility in Tuen Mun. The plastic bottles will be turned into plastic flakes for Starstreet Precinct to upcycle and build the Christmas decorations.
Stay tuned for the special decorations made from the recycled bottles to celebrate the community’s combined effort and contribution to the festive Christmas season later this year.
The Four-Step Process: From Plastic Bottle Recycling to Your Planted Tree
The four-step process is quick and easy! Participants can locate any of the 16 designated recycling bins spotted all over Pacific Place mall, One, Two and Three Pacific Place office buildings, and Starstreet Precinct [please refer to the full list below]. The process is as follows:
- Scan the QR code of the recycling bin via your mobile device for registration. Make sure your plastics are emptied, cleaned and dried before placing them in the bin.
- Upload an image of the plastic bottle for recycling and fill in your personal details on the registration page.
- After submitting the information, you will receive a link to view the exciting reward: a tree planted on your behalf! You can then name the tree yourself.
- Don’t forget to use the EcoMatcher platform to track the growth progress of your brand new, happy tree.
Locations for “Recycle Your Bottles”
There are 16 designated spots where you can send your plastics on their way and get that planted tree reward. Happy recycling!
Recycling Bin Locations | ||
Pacific Place mall | One, Two and Three Pacific Place office buildings | Starstreet Precinct |
|
|
|
Download pictures:
Link: shorturl.at/htBI5
Official website: www.starstreet.com.hk
IG: @starstreethk
FB: starstreet #starstreethk
About Starstreet Precinct
Starstreet Precinct is a vibrant destination in Wan Chai, comprised mainly of Wing Fung Street, Star Street, Moon Street, Sun Street, and St. Francis Yard. Over the years, the neighbourhood has evolved from a quaint, historic landmark, into an eclectic hangout hotspot for those with a unique sense of style and character. Filled with cosy cafés, restaurants, bars, boutique shops with the most coveted fashion selections, galleries and interior design stores, the precinct offers an array of day-to-night experiences. With a focus on community and a passion to foster a sustainable lifestyle for all, Starstreet Precinct and its tenants are collectively working to build a better future together. Connected to Pacific Place and Admiralty station through the Three Pacific Place underground link, the neighbourhood is a hidden gem in the heart of Hong Kong.
#RecycleYourBottles #sustainability #starstreethk
Enhanced Security is Driving Private 5G Network Adoption
Global organizations say they’re ready to team up with partners to make it happen
HONG KONG SAR – Media OutReach – 20 June 2022 – Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybersecurity leader, today announced a new study* revealing the prospect of improved security and privacy capabilities are the main motivations behind private 5G wireless network projects.
To read a full copy of the report, Security Expectations in Private 5G Networks: A journey with partners, please visit here or join the webinar with Trend Micro and 451 Research on June 23 here.
“Private 5G networks are cloudy: two-thirds of respondents told us their deployments will use the technology in some way,” said Eric Hanselman, chief analyst at 451 Research, a part of S&P Global market intelligence. “Yet the cloud’s shared responsibility model means these enterprise customers will need to build their own security capabilities. They said they’ll need expert security partners to help them on this journey. Organizations have great expectations for 5G security, but the quality of their partnerships will be the real differentiator.”
Across smart factories, smart hospitals, and other locations, a growing range of organizations is looking to private 5G networks for coverage, control, low latency, and enhanced security as one of the enterprise networks.
“We see security risk management as one of the key drivers of the business. There is also a strong desire to focus on ensuring organizations achieve situational awareness across IT, OT, and CT communication technology, such as private 5G,” said Yohei Ishihara, security evangelist at Trend Micro.
However, such environments raise a different set of security issues than those in traditional IT and OT environments. While the biggest concern (31%) for respondents is the exposure of data carried on the private wireless network, they also highlighted top key attack vectors, including:
- OS software vulnerabilities (37%)
- Configuration errors (34%)
- Networking equipment vulnerability (33%)
- Device vulnerabilities on RAN (31%) and CORE (27%) networks
- Compromise of connected network (27%)
Adding further challenges to security projects is the fact that nearly a quarter (23%) of respondents expect full integration of private wireless network security with existing operational security. More than half (55%) also want to make this work via automated connections.
Given the complexity of such projects, it is not surprising that over half (58%) of respondents said they would carry out risk assessments either jointly with partners or outsourcing the task completely, while 33% said they’d work with a third party.
Industry-specific security experience (24%) is the top criteria for organizations looking for IT partners, and 19% of them say they want to work with existing partners.
*Trend Micro commissioned 451 Research to poll 400 information security decision-makers from 400 US, Germany, UK, and Spain organizations.
About Trend Micro
Trend Micro, a global cybersecurity leader, helps make the world safe for exchanging digital information. Fueled by decades of security expertise, global threat research, and continuous innovation, Trend Micro’s cybersecurity platform protects hundreds of thousands of organizations and millions of individuals across clouds, networks, devices, and endpoints. As a leader in cloud and enterprise cybersecurity, the platform delivers a powerful range of advanced threat defense techniques optimized for environments like AWS, Microsoft, and Google, and central visibility for better, faster detection and response. With 7,000 employees across 65 countries, Trend Micro enables organizations to simplify and secure their connected world. www.trendmicro.com.hk
#TrendMicro
Laos National Assembly Approves Cabinet Reshuffle and New Appointments
A reshuffle and appointments at the central bank, industry and commerce, and public security sectors have been approved by the ongoing National Assembly (NA) session in Laos.